Get started

MRK

Concave illustrate of MRK......!!!Concave describes an inward curve; its opposite, convex, describes a curve that bulges outward. They are used to describe gentle, subtle curves, like the kinds found in mirrors or lenses. A graph is said to be concave up at a point if the tangent line to the graph at that point lies below the graph in the vicinity of the point and concave down at a point if the tangent line lies above the graph in the vicinity of the point. A point where the concavity changes (from up to down or down to up) is called a point of inflection (POI).
NYSE:MRK
by Jay_shree
28
MERCK IS DIRT CHEAP. $11 BILLION CANCER DRUG. SALES BOOMING!We keep seeing Clinical Stage Companies that are publicly traded, with new FDA Approvals, and the stocks are blasting off. Many of those are trading over $100 with no revenue, profits or earnings. Here Merck is, sitting under $100, beating earnings, with record revenue and profit, and paying an almost 3.00% dividend....It is simply outrageous. Wall Street Corruption at it's best! We took a long position at $82.00 several weeks ago. We feel the stock is worth at minimum, $150.00 all day long. KEYTRUDA alone, not counting any other products manufactured / developed by Merck, or any other divisions of Merck, is forecast to bring in over $11 Billion in sales. Holding for the almost 3% Dividend and for the stock price appreciation into the future. 250,000 LONG @ $82.00 Best of Luck Everyone!
NYSE:MRKLong
by UnknownUnicorn3159981
MRK - DAILY CHARTHi, today we are going to talk about Merck & Co. and its current landscape. Merck & Co. shares are in evidence today as was unveiled that the company it's going to acquire ArQule for $20 per share in cash, totalizing a deal of $2.7 billion. In this season of Mergers and Acquisitions, the Merck & Co. move is based on its interest in pushing its already established leadership on the Cancer-Drug Race, since the company has the top-selling immunotherapy drug Keytruda, as the attention of the pharmaceutical over the sector growths. Thank you for reading and leave your comments if you like. To have access to our exclusive contents, join the Traders Heaven today! Link Below. Disclaimer: All content of Golden Dragon has only educational and informational purposes, and never should be used or take it as financial advice.
NYSE:MRK
by Igor-Silva
Merck & Co. - MRK - SHORTKeep it Simple! Looking at MRK on the Daily there has been an easy setup for a short entry at the 87 range (Orange box). The frequent wicks into this range suggest that there are being fills made for short positions. I have set three profit targets (Green boxes) for this trade, where I will almost completely out of the trade by the third profit target. The trade made very good risk to reward. This trade is not too late for you to enter the short position, with a stop above the top of the range.
NYSE:MRKShort
by djhodnett
MRK needs to find support - what to look forHey everyone, Moving away from the typical crypto posts today. We are checking out MRK. This stock has seen some hefty losses in the past few days, pushing the RSI into a oversold area The increasing bear volume has not been supportive, and the price is breaking past the .382 fib level. The stock is looking to find support, but the last few days have not shown any. Before entering into this long position, we need to see some consolidation on price and bullish movement. Increasing bear volume after a week of losses is also not supportive of increasing price levels. The RSI will need to cool off towards the 40-45 range before we can see some bullish movement. After consolidation, wait for price to retreat to a newly made bullish fib level, signaling a new trend. Once a new high is made, it opens the stock up to a head and shoulders pattern, pointing south again. We would need to see bullish divergence either from volume or from the RSI to bring price higher after this. As is, we are in a bear movement that could pose a falling knife until proper support forms. What do you think? Where could we support form? -Block
NYSE:MRK
by block21e8
Low risk setup for MRKWhy is this setup good? Strong contextual uptrend Price continues moving in the direction of main trend since it bounced at support EMA(100) and EMA(50) Momentum building on MACD 12-26, MACD signal line crossed the 0 line First reaction (contraction) since MACD crossover Trigger Candle testing EMA 3, 6 and 18 Low Setup Risk - just 1.29% in risk Entry rules: Buy Stop order or Manual Buy at 79.58 at the next interval(candle) open Cancel the order at the end of the day if 79.58 does not get triggered Stop Loss (S/L) level at 75.26 (adjust position size accordingly, don't risk more than 3% for your current account balance) Trade management -Move S/L to break-even when price CLOSES above 76.70 Exit rules: -Target 79.58 (Risk-Revard ratio ~3.41)
NYSE:MRKLong
by jorens.zile
MRK - Too Good To Be True?The price here has focused into the obvious descending triangle for almost about a year now! It is not obvious if it will hold or not, but the current company health especially regarding profitability along with price action point towards a downward move, especially after the bullish momentum over the last couple of days. This play is being taken to play on the chance that the stock continues to retrace some of its gains from the past week, ideally before the next earnings report. Let's see how it goes down; it should be a very short-term trade. Stop @ 60.13 Target @ 57.09
NYSE:MRKShort
by themdtrader
2